The blood-brain barrier is the single biggest bottleneck in CNS drug discovery, and a huge obstacle to solving diseases such Alzheimer's, Parkinson's and glioblastoma.
Today, we're excited to release BBB-Nuke, our transport-aware AI platform for predicting BBB to address this.
@AttentionLabsAI we are pushing the frontiers of human cognition and experience with drugs.
Imagine a world where you feel no pain, no addiction, no cognitive limitations, no sleep disturbances. This is a world we imagine.
An Elysium.
The blood-brain barrier is the single biggest bottleneck in CNS drug discovery, and a huge obstacle to solving diseases such Alzheimer's, Parkinson's and glioblastoma.
Today, we're excited to release BBB-Nuke, our transport-aware AI platform for predicting BBB to address this.
Only ~2% of small molecules cross the blood-brain barrier.
The blood-brain barrier has killed more CNS drug programs than bad science ever has. Alzheimer's. Schizophrenia. Depression. Billions spent on compounds that work in a dish and fail to attain enough brain exposure.
We built a pipeline of models to fix this problem.
Introducing BBB-Nuke.
BBB-Nuke is open source.
📄 Paper: https://t.co/hl1oYyY70s
💻 Model & Screening Platform: https://t.co/1ASLig127p
🤖 Use with Claude via MCP: https://t.co/HDSHNExhLa
🤗 Hugging Face dataset: https://t.co/iEzQJCN56p
✍️ Technical blog: https://t.co/7HqhREaGZj
It was a great pleasure hosting attendees at the Attention Labs Launch Event. The conversations were truly engaging, with thoughtful, passionate, and insightful contributions from everyone involved.
We explored the biotech ecosystem, intellectual property governance, and the nuanced questions surrounding how AI-generated value should be protected. The discussion also touched on the current state of AI in science, particularly in drug discovery, and the future trajectories that may shape the field. Finally, we examined the compute and infrastructure requirements necessary to scale and hyperscale AI adoption across industries.
There is a growing narrative that AI will displace humans from positions of importance. At @AttentionLabsAI , we believe the greatest value will come from systems designed to amplify human intelligence rather than replace it. We are working tirelessly toward that mission.
@Techweek_
Today, we’re excited to launch Attention Labs.
For almost 400,000 years, humanity has progressed through a simple but powerful cycle: we learn, we build, and we pass knowledge forward. Every major leap in civilization, from fire to medicine to computing, has expanded what humans are capable of achieving.
We believe AI is the next great tool in that journey.
While much of the world is focused on how AI can replace human work, we are focused on a different question: How can AI amplify human potential?
At Attention Labs, we are building AI to discover brain-enhancing therapeutics, solve neurocognitive diseases, and accelerate the discovery of medicines for the human mind. We believe the greatest opportunity for AI is not creating a world with fewer humans in the loop, but a world where every human can think more clearly, learn faster, create more boldly, and live more fully.
The biggest source of alpha in the age of AI will not come from replacing people. It will come from empowering them.
Our mission is simple:
Make humans the most intelligent entity on Earth.
The future belongs to those who amplify human intelligence, not those who seek to replace it.
We're just getting started.
Attention Labs
https://t.co/3YnJkue1Se
Introducing Attention Labs.
We’re building AI to discover the next generation of brain enhancement therapeutics, solve neurocognitive diseases and build AI tools for neuro drug discovery.
One mission, make humans the most intelligent entity on Earth.
https://t.co/22VFbWI6WX
Introducing Attention Labs.
We’re building AI to discover the next generation of brain enhancement therapeutics, solve neurocognitive diseases and build AI tools for neuro drug discovery.
One mission, make humans the most intelligent entity on Earth.
https://t.co/22VFbWI6WX
AI x BIO is happening at Boston Tech Week.
We’re bringing together founders, investors, scientists, and operators working on the future of AI-driven drug discovery and biological intelligence.
Featuring speakers and panelists from Microsoft, Lilly, SandboxAQ, BIDMC, and more.
We are excited to share that Attention Labs has been accepted into the @msft4startups program
Microsoft has a strong legacy of empowering startups, and we’re thrilled to leverage their cloud & AI ecosystem. We genuinely look forward to having Microsoft as a part of our journey